Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Baker

Showing results (191-200 of 200) with videos related to

Pageof 20
Sort By:
You have reached the last page of results.This site can display upto 200 results.
Scientific Reports|October 27, 2022
Gauging the skin resident Leishmania parasites through a loop mediated isothermal amplification (LAMP) assay in post-kala-azar dermal leishmaniasisPrakash Ghosh, Rajashree Chowdhury, Shomik Maruf, et al.
Oncoimmunology|April 2, 2021
Combination of EP<sub>4</sub> antagonist MF-766 and anti-PD-1 promotes anti-tumor efficacy by modulating both lymphocytes and myeloid cellsYun Wang, Long Cui, Peter Georgiev, et al.
Bioorganic & Medicinal Chemistry Letters|March 18, 2011
Design, synthesis and structure-activity relationships of (indo-3-yl) heterocyclic derivatives as agonists of the CB1 receptor. Discovery of a clinical candidatePaul Ratcliffe, Julia M Adam, James Baker, et al.
The New England Journal of Medicine|February 23, 2017
Inhibiting Plasma Kallikrein for Hereditary Angioedema ProphylaxisAleena Banerji, Paula Busse, Mustafa Shennak, et al.
The New England Journal of Medicine|September 8, 2010
Nanofiltered C1 inhibitor concentrate for treatment of hereditary angioedemaBruce L Zuraw, Paula J Busse, Martha White, et al.
ACS Nano|February 13, 2024
Environmental and Health Impacts of Graphene and Other Two-Dimensional Materials: A Graphene Flagship PerspectiveHazel Lin, Tina Buerki-Thurnherr, Jasreen Kaur, et al.
Medrxiv : the Preprint Server for Health Sciences|November 24, 2025
Genome sequencing of 35,024 predominantly African ancestry persons addresses gaps in genomics and healthcareCecile Avery, Mojgan Babanejad, James Baker, et al.
Bioorganic & Medicinal Chemistry Letters|March 1, 2011
Synthesis and SAR studies of novel 2-(4-oxo-2-aryl-quinazolin-3(4H)-yl)acetamide vasopressin V1b receptor antagonistsSusan E Napier, Jeffrey J Letourneau, Nasrin Ansari, et al.
Bioorganic & Medicinal Chemistry Letters|May 15, 2017
Identification of quinazoline based inhibitors of IRAK4 for the treatment of inflammationGraham F Smith, Michael D Altman, Brian Andresen, et al.
The New England Journal of Medicine|March 23, 2017
Prevention of Hereditary Angioedema Attacks with a Subcutaneous C1 InhibitorHilary Longhurst, Marco Cicardi, Timothy Craig, et al.
Pageof 20

Showing results (191-200 of 200) with videos related to

Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 200 results.
Scientific Reports|October 27, 2022
Gauging the skin resident Leishmania parasites through a loop mediated isothermal amplification (LAMP) assay in post-kala-azar dermal leishmaniasisPrakash Ghosh, Rajashree Chowdhury, Shomik Maruf, et al.
Oncoimmunology|April 2, 2021
Combination of EP<sub>4</sub> antagonist MF-766 and anti-PD-1 promotes anti-tumor efficacy by modulating both lymphocytes and myeloid cellsYun Wang, Long Cui, Peter Georgiev, et al.
Bioorganic & Medicinal Chemistry Letters|March 18, 2011
Design, synthesis and structure-activity relationships of (indo-3-yl) heterocyclic derivatives as agonists of the CB1 receptor. Discovery of a clinical candidatePaul Ratcliffe, Julia M Adam, James Baker, et al.
The New England Journal of Medicine|February 23, 2017
Inhibiting Plasma Kallikrein for Hereditary Angioedema ProphylaxisAleena Banerji, Paula Busse, Mustafa Shennak, et al.
The New England Journal of Medicine|September 8, 2010
Nanofiltered C1 inhibitor concentrate for treatment of hereditary angioedemaBruce L Zuraw, Paula J Busse, Martha White, et al.
ACS Nano|February 13, 2024
Environmental and Health Impacts of Graphene and Other Two-Dimensional Materials: A Graphene Flagship PerspectiveHazel Lin, Tina Buerki-Thurnherr, Jasreen Kaur, et al.
Medrxiv : the Preprint Server for Health Sciences|November 24, 2025
Genome sequencing of 35,024 predominantly African ancestry persons addresses gaps in genomics and healthcareCecile Avery, Mojgan Babanejad, James Baker, et al.
Bioorganic & Medicinal Chemistry Letters|March 1, 2011
Synthesis and SAR studies of novel 2-(4-oxo-2-aryl-quinazolin-3(4H)-yl)acetamide vasopressin V1b receptor antagonistsSusan E Napier, Jeffrey J Letourneau, Nasrin Ansari, et al.
Bioorganic & Medicinal Chemistry Letters|May 15, 2017
Identification of quinazoline based inhibitors of IRAK4 for the treatment of inflammationGraham F Smith, Michael D Altman, Brian Andresen, et al.
The New England Journal of Medicine|March 23, 2017
Prevention of Hereditary Angioedema Attacks with a Subcutaneous C1 InhibitorHilary Longhurst, Marco Cicardi, Timothy Craig, et al.
Pageof 20